The nature and magnitude of cognitive impairment related to sleep and wake disorders is increasingly being considered by biopharmaceutical teams evaluating the impact of novel therapeutic candidates in this area.
With decades of experience in cognitive assessment, Cogstate provides guidance and support to help your team gather quality data via validated digital tests of sustained attention and cognition, as well as standard outcome measurement collection.
Please fill out the form below to download the fact sheet and learn more.
